These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. Bidlingmaier S, Zhu X, Liu B. J Mol Med (Berl); 2008 Sep; 86(9):1025-32. PubMed ID: 18535813 [Abstract] [Full Text] [Related]
9. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression. Gambelli F, Sasdelli F, Manini I, Gambarana C, Oliveri G, Miracco C, Sorrentino V. Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848 [Abstract] [Full Text] [Related]
10. Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection. Sgambato A, Puglisi MA, Errico F, Rafanelli F, Boninsegna A, Rettino A, Genovese G, Coco C, Gasbarrini A, Cittadini A. J Cell Physiol; 2010 Jul; 224(1):234-41. PubMed ID: 20333645 [Abstract] [Full Text] [Related]
12. Insight into the complex regulation of CD133 in glioma. Campos B, Herold-Mende CC. Int J Cancer; 2011 Feb 01; 128(3):501-10. PubMed ID: 20853315 [Abstract] [Full Text] [Related]
14. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors. Ernst A, Aigner M, Nakata S, Engel F, Schlotter M, Kloor M, Brand K, Schmitt S, Steinert G, Rahbari N, Koch M, Radlwimmer B, Weitz J, Lichter P. Pathology; 2011 Apr 01; 43(3):220-7. PubMed ID: 21436631 [Abstract] [Full Text] [Related]
15. CD133 is essential for glioblastoma stem cell maintenance. Brescia P, Ortensi B, Fornasari L, Levi D, Broggi G, Pelicci G. Stem Cells; 2013 May 01; 31(5):857-69. PubMed ID: 23307586 [Abstract] [Full Text] [Related]
16. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Wang J, Sakariassen PØ, Tsinkalovsky O, Immervoll H, Bøe SO, Svendsen A, Prestegarden L, Røsland G, Thorsen F, Stuhr L, Molven A, Bjerkvig R, Enger PØ. Int J Cancer; 2008 Feb 15; 122(4):761-8. PubMed ID: 17955491 [Abstract] [Full Text] [Related]
18. CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope. Mak AB, Blakely KM, Williams RA, Penttilä PA, Shukalyuk AI, Osman KT, Kasimer D, Ketela T, Moffat J. J Biol Chem; 2011 Nov 25; 286(47):41046-56. PubMed ID: 21937449 [Abstract] [Full Text] [Related]
19. Expression of multidrug resistance genes in normal and cancer stem cells. Shervington A, Lu C. Cancer Invest; 2008 Jun 25; 26(5):535-42. PubMed ID: 18568776 [Abstract] [Full Text] [Related]
20. Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma. Hermansen SK, Christensen KG, Jensen SS, Kristensen BW. J Histochem Cytochem; 2011 Apr 25; 59(4):391-407. PubMed ID: 21411810 [Abstract] [Full Text] [Related] Page: [Next] [New Search]